Therapeutic Innovation Award

The Therapeutic Innovation Award supports innovative research exploring novel approaches for targeting “undruggable” proteins that play critical roles in cancer, thus laying the foundation for future drug discovery efforts.

Issued in partnership with the Chordoma Foundation, these Therapeutic Innovation Awards target the transcription factor brachyury, a key driver of chordoma, a rare tumor of the skull base and spine. Inaugural Award recipients were announced in November 2018.